BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25217962)

  • 21. Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort.
    Nicoletti P; Carr DF; Barrett S; McEvoy L; Friedmann PS; Shear NH; Nelson MR; Chiriac AM; Blanca-López N; Cornejo-García JA; Gaeta F; Nakonechna A; Torres MJ; Caruso C; Valluzzi RL; Floratos A; Shen Y; Pavlos RK; Phillips EJ; Demoly P; Romano A; Blanca M; Pirmohamed M
    J Allergy Clin Immunol; 2021 May; 147(5):1830-1837.e15. PubMed ID: 33058932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA associations with multiple sclerosis in Greece.
    Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
    J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
    Kozuka R; Enomoto M; Sato-Matsubara M; Yoshida K; Motoyama H; Hagihara A; Fujii H; Uchida-Kobayashi S; Morikawa H; Tamori A; Kawada N; Murakami Y
    J Gastroenterol Hepatol; 2019 May; 34(5):937-946. PubMed ID: 30160782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic association study of the HLA class II alleles DRB1, DQA1, and DQB1 in patients with pharmacoresistant temporal lobe epilepsy associated with mesial hippocampal sclerosis.
    Horta WG; Paradela E; Figueiredo A; Meira ID; Pereira VC; Rego CC; Oliveira R; Andraus ME; de Lacerda GC; Moura P; de Souza JP; Paiva CL; Alves-Leon SV
    Seizure; 2015 Sep; 31():7-11. PubMed ID: 26362370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA class II immunogenetics of IDDM in Yemenite Jews.
    Israel S; Kwon OJ; Weintrob N; Sprecher E; Bloch K; Assa S; Brautbar C; Vardi P
    Hum Immunol; 1998 Nov; 59(11):728-33. PubMed ID: 9796741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid signatures in the HLA class II peptide-binding region associated with protection/susceptibility to the severe West Nile Virus disease.
    Sarri CA; Papadopoulos GE; Papa A; Tsakris A; Pervanidou D; Baka A; Politis C; Billinis C; Hadjichristodoulou C; Mamuris Z;
    PLoS One; 2018; 13(10):e0205557. PubMed ID: 30379846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DRB1, -DQA1 and -DQB1 genotyping of 180 Czech individuals from the Czech Republic pop 3.
    Zajacova M; Kotrbova-Kozak A; Cerna M
    Hum Immunol; 2016 Apr; 77(4):365-6. PubMed ID: 26867812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population.
    Balducci-Silano PL; Layrisse Z; Dominguez E; Amaro R; Gunczler P; Lanes R; Zaro R
    Eur J Immunogenet; 1994 Dec; 21(6):405-14. PubMed ID: 9098450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Kakuta Y; Kawai Y; Okamoto D; Takagawa T; Ikeya K; Sakuraba H; Nishida A; Nakagawa S; Miura M; Toyonaga T; Onodera K; Shinozaki M; Ishiguro Y; Mizuno S; Takahara M; Yanai S; Hokari R; Nakagawa T; Araki H; Motoya S; Naito T; Moroi R; Shiga H; Endo K; Kobayashi T; Naganuma M; Hiraoka S; Matsumoto T; Nakamura S; Nakase H; Hisamatsu T; Sasaki M; Hanai H; Andoh A; Nagasaki M; Kinouchi Y; Shimosegawa T; Masamune A; Suzuki Y;
    J Gastroenterol; 2018 Sep; 53(9):1065-1078. PubMed ID: 29923122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
    Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
    J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DQA1, DQB1 and DRB1 alleles associated with Takayasu arteritis in the Chinese Han population.
    Lv N; Wang Z; Dang A; Zhu X; Liu Y; Zheng D; Liu G
    Hum Immunol; 2015 Apr; 76(4):241-4. PubMed ID: 25636572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide association study of susceptibility loci for cervical cancer.
    Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
    J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three new HLA class II alleles: DRB1*08:70, DQA1*01:13 and DQA1*03:01:03.
    Balas A; Planelles D; García-Sánchez F; Prior C; Vicario JL
    Int J Immunogenet; 2016 Apr; 43(2):107-8. PubMed ID: 26762682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the Late Onset alzheimer's Disease Associated
    Zhang X; Zou M; Wu Y; Jiang D; Wu T; Zhao Y; Wu D; Cui J; Li G
    Am J Alzheimers Dis Other Demen; 2022; 37():15333175221085066. PubMed ID: 35341343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A super enhancer controls expression and chromatin architecture within the MHC class II locus.
    Majumder P; Lee JT; Rahmberg AR; Kumar G; Mi T; Scharer CD; Boss JM
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31753848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
    Qi J; Wang TJ; Li HX; Wu D; Du D; Wu JH; Shang LX; Chen L; Wang MN; Wang XF
    Hum Immunol; 2020 Dec; 81(12):685-691. PubMed ID: 32693929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India.
    Raha O; Sarkar B; Lakkakula BV; Pasumarthy V; Godi S; Chowdhury S; Raychaudhuri P; Vadlamudi RR
    J Biomed Sci; 2013 Feb; 20(1):12. PubMed ID: 23441825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility.
    Vargas-Alarcón G; Salgado N; Granados J; Gómez-Casado E; Martinez-Laso J; Alcocer-Varela J; Arnaiz-Villena A; Alarcón-Segovia D
    Hum Immunol; 2001 Aug; 62(8):814-20. PubMed ID: 11476905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB and HLA-DQA/HLA-DQB allele and haplotype frequencies in Iranian patients with aggressive periodontitis.
    Jazi MM; Solgi G; Roosta HA; Noshad S; Moslemi N; Sadrimanesh R; Moradi B; Amirzargar AA
    J Periodontal Res; 2013 Aug; 48(4):533-9. PubMed ID: 23317308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.